The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future
Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 3
Abstract
Muscle invasion is present in approximately thirty percent of bladder cancers. Radical cystectomy and bilateral pelvic lymph node dissection following neoadjuvant chemotherapy is the recommended treatment for muscle invasive bladder cancer. Local and distant relapses are seen in a significant proportion of patients with surgery alone. Micrometastases at the time of diagnosis that cannot be detected by imaging may be responsible for these relapses. The aim of neoadjuvant and adjuvant therapies is to eliminate these micrometastases. Several randomized trials have shown that platinum-based combination neoadjuvant chemotherapy can improve survival outcomes, compared with locoregional treatment alone. Although the proportion of patients receiving treatment has increased compared to previous years, it is still low. Immunotherapies in neoadjuvant treatment are promising in the appropriate patient group. In this article, we aimed to review current neoadjuvant treatment strategies in muscle invasive bladder cancer in the literature.
Authors and Affiliations
Özlem Ercelep
Keywords
Related Articles
- EP ID EP688784
- DOI 10.4274/uob.galenos.2020.1447
- Views 125
- Downloads 0
Effect of High-dose Ascorbic Acid on Prostate Cancer Cells and Angiogenesis
Objective: Ascorbic acid (AA), at physiological concentrations, is a well known anti-oxidant but, at higher concentrations, it can be selectively toxic to cancer cells. Controversial data have shown that administration o...
How Does Antibiotherapy Affect the Clinical Outcomes of the Patients with High Prostate Specific Antigen? An Observational Study
Objective: The purpose of this observational study is to investigate the effect of urologists daily practice antibiotic usage on prostate biopsy rates and clinically insignificant cancer diagnosis rates in patients with...
Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes?
Homologous recombination (HR) is a major repair mechanism of DNA damage. Platin-based agents are known to be more effective in patients with impaired HR mechanism. Previous studies combined platin compounds with docetaxe...
Risk Factors Affecting Complications Due to Prostate Biopsy
Objective: Currently, transrectal ultrasound (TRUS) guided prostate biopsy is the standard method used for prostate cancer detection. In the last decade, hospitalization due to complications has increased, especially due...
5-Hydroxyuracil Incision Activity Varies According to the Histological Grade of Non-muscle-invasive Bladder Cancer
Objective: High levels of endonuclease III-like 1 (NTHL1) DNA glycosylase, which plays a role in the first step of the base excision repair pathway, has been related to cancer initiation and progression. 5-hydroxyuracil...